These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 11792070

  • 1. Antibodies against human papillomavirus type 16 and 18 E6 and E7 proteins in cervicovaginal washings and serum of patients with cervical neoplasia.
    Tjiong MY, Zumbach K, Schegget JT, van der Vange N, Out TA, Pawlita M, Struyk L.
    Viral Immunol; 2001; 14(4):415-24. PubMed ID: 11792070
    [Abstract] [Full Text] [Related]

  • 2. Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer.
    Jin Y, Choi JW, Kim HJ, Eddouzi J, Kim SC, Ju W, Kim YH, Kim HJ.
    Cancer Med; 2018 Nov; 7(11):5655-5664. PubMed ID: 30353680
    [Abstract] [Full Text] [Related]

  • 3. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
    Zumbach K, Kisseljov F, Sacharova O, Shaichaev G, Semjonova L, Pavlova L, Pawlita M.
    Int J Cancer; 2000 Feb 01; 85(3):313-8. PubMed ID: 10652419
    [Abstract] [Full Text] [Related]

  • 4. Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasias.
    Sasagawa T, Inoue M, Tanizawa O, Yutsudo M, Hakura A.
    Jpn J Cancer Res; 1992 Jul 01; 83(7):705-13. PubMed ID: 1325428
    [Abstract] [Full Text] [Related]

  • 5. Serologic response in human papillomavirus-associated invasive cervical cancer.
    Viscidi RP, Sun Y, Tsuzaki B, Bosch FX, Muñoz N, Shah KV.
    Int J Cancer; 1993 Nov 11; 55(5):780-4. PubMed ID: 8244575
    [Abstract] [Full Text] [Related]

  • 6. Development and validation of a multiplex immunoassay for the simultaneous quantification of type-specific IgG antibodies to E6/E7 oncoproteins of HPV16 and HPV18.
    Layman H, Rickert KW, Wilson S, Aksyuk AA, Dunty JM, Natrakul D, Swaminathan N, DelNagro CJ.
    PLoS One; 2020 Nov 11; 15(3):e0229672. PubMed ID: 32214362
    [Abstract] [Full Text] [Related]

  • 7. Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patients.
    Nindl I, Benitez-Bribiesca L, Berumen J, Farmanara N, Fisher S, Gross G, Lopez-Carillo L, Müller M, Tommasino M, Vazquez-Curiel A.
    Arch Virol; 1994 Nov 11; 137(3-4):341-53. PubMed ID: 7524466
    [Abstract] [Full Text] [Related]

  • 8. Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma.
    Sun Y, Eluf-Neto J, Bosch FX, Muñoz N, Walboomers JM, Meijer CJ, Shah KV, Clayman B, Viscidi RP.
    Cancer Epidemiol Biomarkers Prev; 1999 Oct 11; 8(10):935-40. PubMed ID: 10548324
    [Abstract] [Full Text] [Related]

  • 9. Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia.
    Kadish AS, Ho GY, Burk RD, Wang Y, Romney SL, Ledwidge R, Angeletti RH.
    J Natl Cancer Inst; 1997 Sep 03; 89(17):1285-93. PubMed ID: 9293919
    [Abstract] [Full Text] [Related]

  • 10. Immunologic diagnosis and monitoring of cervical cancers using in vitro translated HPV proteins.
    Chee YH, Namkoong SE, Kim DH, Kim SJ, Park JS.
    Gynecol Oncol; 1995 May 03; 57(2):226-31. PubMed ID: 7729739
    [Abstract] [Full Text] [Related]

  • 11. A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection.
    Monroy-García A, Gómez-Lim MA, Weiss-Steider B, la Rosa GP, Hernández-Montes J, Pérez-Saldaña K, Tapia-Guerrero YS, Toledo-Guzmán ME, Santiago-Osorio E, Sanchez-Peña HI, Mora-García Mde L.
    Virol J; 2011 Feb 09; 8():59. PubMed ID: 21306638
    [Abstract] [Full Text] [Related]

  • 12. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
    Rosales R, López-Contreras M, Cortes RR.
    J Med Virol; 2001 Dec 09; 65(4):736-44. PubMed ID: 11745939
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus type 16: relationship to cervical intraepithelial neoplasia.
    Nakagawa M, Stites DP, Farhat S, Sisler JR, Moss B, Kong F, Moscicki AB, Palefsky JM.
    J Infect Dis; 1997 Apr 09; 175(4):927-31. PubMed ID: 9086151
    [Abstract] [Full Text] [Related]

  • 14. Comparison of peptide enzyme-linked immunosorbent assay and radioimmunoprecipitation assay with in vitro-translated proteins for detection of serum antibodies to human papillomavirus type 16 E6 and E7 proteins.
    Sun Y, Shah KV, Müller M, Muñoz N, Bosch XF, Viscidi RP.
    J Clin Microbiol; 1994 Sep 09; 32(9):2216-20. PubMed ID: 7529250
    [Abstract] [Full Text] [Related]

  • 15. Novel oligomannose liposome-DNA complex DNA vaccination efficiently evokes anti-HPV E6 and E7 CTL responses.
    Mizuuchi M, Hirohashi Y, Torigoe T, Kuroda T, Yasuda K, Shimizu Y, Saito T, Sato N.
    Exp Mol Pathol; 2012 Feb 09; 92(1):185-90. PubMed ID: 22032938
    [Abstract] [Full Text] [Related]

  • 16. Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients.
    Bleul C, Müller M, Frank R, Gausepohl H, Koldovsky U, Mgaya HN, Luande J, Pawlita M, ter Meulen J, Viscidi R.
    J Clin Microbiol; 1991 Aug 09; 29(8):1579-88. PubMed ID: 1722219
    [Abstract] [Full Text] [Related]

  • 17. Relation between HPV-16 serology and clinico-pathological data in cervical carcinoma patients: prognostic value of anti-E6 and/or anti-E7 antibodies.
    Baay MF, Duk JM, Groenier KH, Burger MP, de Bruijn HW, Hollema H, Stolz E, Herbrink P.
    Cancer Immunol Immunother; 1997 Jun 09; 44(4):211-5. PubMed ID: 9222279
    [Abstract] [Full Text] [Related]

  • 18. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.
    Jiang B, Xue M.
    Genet Mol Res; 2015 Sep 08; 14(3):10473-81. PubMed ID: 26400278
    [Abstract] [Full Text] [Related]

  • 19. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer.
    Meschede W, Zumbach K, Braspenning J, Scheffner M, Benitez-Bribiesca L, Luande J, Gissmann L, Pawlita M.
    J Clin Microbiol; 1998 Feb 08; 36(2):475-80. PubMed ID: 9466762
    [Abstract] [Full Text] [Related]

  • 20. Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer.
    Combes JD, Pawlita M, Waterboer T, Hammouda D, Rajkumar T, Vanhems P, Snijders P, Herrero R, Franceschi S, Clifford G.
    Int J Cancer; 2014 Nov 15; 135(10):2453-61. PubMed ID: 24729277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.